"10.1371_journal.pone.0063959","plos one","2013-05-21T00:00:00Z","Martin Zalesak; Kevin Francis; Alex Gedeon; John Gillis; Kyle Hvidsten; Phyllis Kidder; Hong Li; Derek Martyn; Leslie Orne; Amanda Smith; Ann Kwong","Trinity Partners, LLC, Waltham, Massachusetts, United States of America; Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts, United States of America","Conceived and designed the experiments: MZ LO AK. Analyzed the data: MZ KF AG JG HL DM LO AS AK. Contributed reagents/materials/analysis tools: KF JG. Wrote the paper: MZ HL DM LO AK. Critical revision of the manuscript for important intellectual content: MZ KH PK HL DM LO AK. Obtained funding: KH AK.","KH and PK are employees and stock owners of Vertex Pharmaceuticals Incorporated. AK is a former employee of Vertex Pharmaceuticals Incorporated and owned stock and options in the company at the time this research was performed. MZ, KF, AG, JG, HL, DM, LO, AS are all current or former employees of Trinity Partners, LLC, a for-profit healthcare consultancy. MZ received conference travel grants from Vertex Pharmaceuticals Incorporated to present selected portions of the data described in this manuscript. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","05","Martin Zalesak","MZ",11,TRUE,3,NA,9,5,TRUE,TRUE,FALSE,0,NA,FALSE
